Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles |
Liu, Cunbao
(Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College)
Yao, Yufeng (Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College) Yang, Xu (Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College) Bai, Hongmei (Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College) Huang, Weiwei (Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College) Xia, Ye (Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College) Ma, Yanbing (Yunnan Key Laboratory of Vaccine Research and Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College) |
1 | Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM. 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer 121: 621-632. DOI ScienceOn |
2 | Liu C, Yang X, Yao Y, Huang W, Sun W, Ma Y. 2014. Diverse expression levels of two codon-optimized genes that encode human papillomavirus type 16 major protein L1 in Hansenula polymorpha. Biotechnol. Lett. 36: 937-945. DOI ScienceOn |
3 | Mbayeel HS, Gheit T, Dem A, McKay-Chopin S, ToureKane NC, Mboup S, et al. 2014. Human papillomavirus infection in women in four regions of Senegal. J. Med. Virol. 86: 248-256. DOI ScienceOn |
4 | Quek SC, Lim BK, Domingo E, Soon R, Park JS, Vu TN, et al. 2013. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical intraepithelial neoplasia across 5 countries in Asia. Int. J. Gynycol. Cancer 23: 148-156. DOI ScienceOn |
5 | Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K. 2013. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand. BMC Infect. Dis. 13: 114. DOI |
6 | Takehara K, Toda T, Nishimura T, Sakane J, Kawakami Y, Mizunoe T, et al. 2011. Human papillomavirus types 52 and 58 are prevalent in uterine cervical squamous lesions from Japanese women. Patholog. Res. Int. 2011: 246936. |
7 | Zhao FH, Zhu FC, Chen W, Li J, Hu YM, Hong Y, et al., HPV-039 study group. 2014. Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial. Int. J. Cancer 135: 2604-2611. DOI ScienceOn |
8 | Zhao Q, Allen MJ, Wang Y, Wang B, Wang N, Shi L, Sitrin RD. 2012. Disassembly and reassembly improves morphology and thermal stability of human papillomavirus type 16 virus-like particles. Nanomedicine 8: 1182-1189. DOI ScienceOn |
9 | Lee EH, Um TH, Chi HS, Hong YJ, Cha YJ. 2012. Prevalence and distribution of human papillomavirus infection in Korean women as determined by restriction fragment mass polymorphism assay. J. Kor. Med. Sci. 27: 1091-1097. DOI ScienceOn |
10 | Hoang HT, Ishizaki A, Nguyen CH, Tran VT, Matsushita K, Saikawa K, et al. 2013. Infection with high-risk HPV types among female sex workers in northern Vietnam. J. Med. Virol. 85: 288-294. DOI ScienceOn |
11 | Lin H, Ma YY, Moh JS, Ou YC, Shen SY, ChangChien CC. 2006. High prevalence of genital papillomavirus type 52 and 58 in women attending gynecologic practitioners in south Taiwan. Gynecol. Oncol. 101: 40-45. DOI ScienceOn |
12 | Kim HJ, Kwag HL, Kim HJ. 2013. Codon optimization of the human papillomavirus type 58 L1 gene enhances the expression of soluble L1 protein in Saccharomyces cerevisiae. Biotechnol. Lett. 35: 413-421. DOI ScienceOn |
13 | Kirnbauer R, Booy F, Cheng N, Lowy DR, Schiller JT. 1992. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89: 12180-12184. DOI ScienceOn |
14 | Li HM, Liang GJ, Yin YP, Wang QQ, Zheng ZJ, Zhou JJ, et al. 2012. Prevalence and genotype distribution of human papillomavirus infection among female sex workers in Guangxi, China: implications for interventions. J. Med. Virol. 84: 798-803. DOI ScienceOn |
15 | Garland SM, Smith JS. 2010. Human papillomavirus vaccines: current status and future prospects. Drugs 70: 1079-1098. DOI ScienceOn |
16 | Hanumantha Rao N, Baji Babu P, Rajendra L, Sriraman R, Pang YY, Schiller JT, Srinivasan VA 2011. Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles. Vaccine 29: 7326-7334. DOI ScienceOn |
17 | Chui SH, Szeto YT, Lam CW. 2012. Human papillomavirus infection in Macau women. Public Health 126: 600-604. DOI ScienceOn |
18 | Bian G, Cheng Y, Wang Z, Hu Y, Zhang X, Wu M, et al. 2009. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HSsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Vaccine 28: 187-194. DOI ScienceOn |
19 | Chen Q, Xie LX, Qing ZR, Li LJ, Luo ZY, Lin M, et al. 2012. Epidemiologic characterization of human papillomavirus infection in rural Chaozhou, eastern Guangdong Province of China. PLoS One. 7: e32149. DOI |
20 | Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. 2010. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect. Dis. 202: 1789-1799. DOI ScienceOn |
21 | Deschuyteneer M, Elouahabi A, Plainchamp D, Plisnier M, Soete D, Corazza Y, et al. 2010. Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in CervarixTM, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine. Hum. Vaccine 6: 407-419. DOI |
22 | Diminsky D, Schirmbeck R, Reimann J, Barenholz Y. 1997. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 15: 637-647. DOI ScienceOn |
23 | Faber KN, Haima P, Harder W, Veenhuis M, AB G. 1994. Highly-efficient electrotransformation of the yeast Hansenula polymorpha. Curr. Genet. 25: 305-310. DOI |